Lauren Silvernail

(Mrs. Lauren Silvernail)

Currently holds positions in Evolus Inc, Ista Pharmaceuticals LLC and Nicox SA

Positions

Position Company Period
Chief Financial Officer, Executive Vice President - Corporate Development Evolus Inc May 29, 2018 -
Chief Financial Officer, Vice President - Corporate Development Ista Pharmaceuticals LLC March 1, 2003 -
Non-Executive Independent Director Nicox SA May 16, 2017 -
Chief Financial Officer, Chief Business Officer Revance Therapeutics Inc Dec. 14, 2015 - May 27, 2018
Chief Financial Officer, Executive Vice President of Corporate Development Revance Therapeutics Inc None -
Lauren Silvernail's trades of Evolus Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-18 2022-05-18
US Evolus Inc (EOLS)
S Sale
52,015 -26.9%
12.42
USD 646,026 		52,015 -26.9% 12.42 USD 646,026
2022-05-18 2022-05-17
US Evolus Inc (EOLS)
S Sale
16,189 -7.7%
13.92
USD 225,354 		16,189 -7.7% 13.92 USD 225,354
2022-03-10 2022-03-08
US Evolus Inc (EOLS)
PS Planned sale
10,192 -4.6%
9.73
USD 99,121 		10,192 -4.6% 9.73 USD 99,121
2021-01-26 2021-01-25
US Evolus Inc (EOLS)
PS Planned sale
2,699 -2.9%
7.46
USD 20,135 		2,699 -2.9% 7.46 USD 20,135
2019-05-31 2019-05-31
US Evolus Inc (EOLS)
S Sale
2,612 -8.7%
13.53
USD 35,352 		2,612 -8.7% 13.53 USD 35,352
2017-05-24 2017-05-22
S Sale
1,793 -4.7%
20.20
USD 36,212 		1,793 -4.7% 20.20 USD 36,212
// ... existing code ... // ... rest of the file ...